Berry Genomics, a Beijing genetic testing company, will be acquired by Chengdu Tianxing Instrument & Meter, a Shenzhen-listed auto parts company. Founded in 2010, Berry makes a noninvasive prenatal test that is widely available. The planned transaction was announced in a Tianxing filing that did not include any financial details, except that Tianxing will issue shares for Berry. Tianxing, which has a market cap of $500 million, has not traded since June 14.
